Pediatric Asthma Exacerbations – 14 Day ED Return Visit Risk Factors

Ricardo Aguilar,Chloe Knudsen-Robbins,Louis Ehwerhemuepha,William Feaster,Sunil Kamath,Theodore W. Heyming

DOI: https://doi.org/10.1016/j.jemermed.2024.02.002

IF: 1.473

2024-02-18

Journal of Emergency Medicine

Abstract:Background Asthma, the most common chronic disease of childhood, can affect a child's physical and mental health, and their social/emotional development. Objectives To identify factors associated with ED return visits for asthma exacerbations within 14 days of an initial visit. Methods This was a retrospective review from Cerner Real-World Database for patients 5-18 seen at an ED for an asthma exacerbation and discharged home at the index ED visit. Asthma visits were defined as encounters in which a patient was diagnosed with asthma and a beta agonist, anticholinergic, or systemic steroid was ordered or prescribed at that encounter. Return visits were ED visits for asthma within 14 days of an index ED visit. Data including demographics, ED evaluation/treatment, healthcare utilization, and past medical history were collected. Data were analyzed via logistic regression mixed effects model. Results 80,434 index visits and 17,443 return visits met inclusion criteria. Prior ED return visits in the past year were associated with an increased odds ratio (OR) of a return visit (OR 2.12; CI 2.07, 2.16). History of pneumonia, a concomitant diagnosis of pneumonia, and fever were associated with increased odds of a return visit (OR 1.19; CI 1.10, 1.29, OR 1.15; CI 1.04, 1.28, OR 1.20; CI 1.11, 1.30). Conclusions Several variables appear to be associated with statistically significant increased odds of ED return visits. These findings indicate a potentially identifiable population of at-risk patients who may benefit from additional evaluation, planning, and/or education prior to discharge.

emergency medicine